Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Renal Solutions Inc.

Division of Fresenius SE & Co. KGAA
www.renalsolutionsinc.com

Latest From Renal Solutions Inc.

Renal Devices: New Blood Revitalizes Dialysis Industry

CMS pays 33% of its budget for patients with end stage kidney disease, a group that, in terms of patient numbers, accounts for less than 1% of the Medicare population. For all this money spent, mortality rates remain high--the one year mortality rate for patients on hemodialysis stands at 24%, a survival rate that's worse than that of metastatic cancer. In an industry traditionally resistant to change, however, changes are coming, brought about by reimbursement changes and a delivery model that can't scale-up to meet a growing population, making room for new start-ups in the space.
Medical Device Reimbursement

Deals Update (01/2008)

A roundup of recent medtech strategic alliances, mergers & acquisitions and financings.
Medical Device

Deals Update

A roundup of recent medtech strategic alliances, mergers & acquisitions and financings.
Medical Device

NxStage: Bringing Dialysis Home

After years of steady growth, the dialysis market is predicted to increase dramatically, and this growth will severely strain the current system of dialysis clinics where most of these procedures are performed. Home hemodialysis could help relieve this bottleneck but has not been a viable alternative to date because of the lack of effective device innovation. NxStage Medical has developed a system that makes home hemodialysis a therapeutic option, which could dramatically improve both the health and lifestyle of patients, along with the economic future of the dialysis market.
Medical Device Reimbursement
See All

Company Information

  • Industry
  • Medical Devices
  • Therapeutic Areas
  • Renal System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Fresenius SE & Co. KGAA
  • Senior Management
  • Peter M DeComo, Chmn. & CEO
    David J Haffner, SVP, CFO
  • Contact Info
  • Renal Solutions Inc.
    Phone: (724) 772-6900
    770 Commonwealth Dr.
    Ste. 101
    Warrendale, PA 15086
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register